Rchr
J-GLOBAL ID:201701003337928676   Update date: Oct. 26, 2024

Yasujima Tomoya

ヤスジマ トモヤ | Yasujima Tomoya
Affiliation and department:
Job title: Associate Professor
Research field  (1): Clinical pharmacy
Research keywords  (2): 薬物動態 ,  トランスポーター
Research theme for competitive and other funds  (7):
  • 2023 - 2026 新規コリントランスポーター類の分子機能と生理的及び薬物動態的役割
  • 2023 - 2026 Elucidation of substrate recognition mechanism of SLC19A3 to establish the molecular basis for medical applications
  • 2020 - 2023 新規ポリアミントランスポーターの機能及び生理的役割の解明
  • 2020 - 2023 Elucidation of molecular mechanism that triggers onset of gout from hyperuricemia
  • 2018 - 2020 Relationship between novel thiamine pool mechanism and proliferative capacity in cancer cells
Show all
Papers (32):
  • SLC35G1 is a highly chloride-sensitive transporter responsible for the basolateral membrane transport in intestinal citrate absorption. eLife. 2024
  • Akira Hosooka, Tomoya Yasujima, Ayano Murata, Takahiro Yamashiro, Hiroaki Yuasa. Identification of human-specific amino acid residues governing atenolol transport via organic cation transporter 2. Biochemical Pharmacology. 2024. 116514-116514
  • Shogo Akino, Tomoya Yasujima, Rei Shibutani, Takahiro Yamashiro, Hiroaki Yuasa. Involvement of Proton-Coupled SLC49A4-Mediated Transport in the Export of Lysosomally Trapped Pyrilamine. Drug Metabolism and Disposition. 2023. 52. 1. 19-25
  • Shogo Akino, Tomoya Yasujima, Takahiro Yamashiro, Hiroaki Yuasa. Disrupted in renal carcinoma 2 (DIRC2/SLC49A4) is an H+-driven lysosomal pyridoxine exporter. Life Science Alliance. 2023. 6. 2. e202201629-e202201629
  • Kohei Miyake, Tomoya Yasujima, Syunsuke Takahashi, Takahiro Yamashiro, Hiroaki Yuasa. Identification of the amino acid residues involved in the species-dependent differences in the pyridoxine transport function of SLC19A3. Journal of Biological Chemistry. 2022. 298. 8. 102161-102161
more...
Patents (1):
  • 小腸上皮細胞特異的な尿酸トランスポーター及びその利用
Books (2):
  • 【高尿酸血症Update】尿酸の全身動態を支配する代謝酵素・トランスポーター
    日本腎臓病薬物療法学会誌 2022
  • 【生活習慣と免疫異常】痛風の分子病態
    臨床免疫・アレルギー科 2022
Education (3):
  • 2009 - 2012 Nagoya City University Graduate School of Pharmaceutical Sciences
  • 2007 - 2009 Nagoya City University Graduate School of Pharmaceutical Sciences
  • 2003 - 2007 Nagoya City University Medicin Medicin
Work history (7):
  • 2023/06 - 現在 Nagoya City University Graduate School of Pharmaceutical Sciences Department of Biopharmaceutics Associate Professor
  • 2018/04 - 2023/05 Nagoya City University Graduate School of Pharmaceutical Sciences, Department of Biopharmaceutics
  • 2019/10 - 2020/04 カリフォルニア大学アーバイン校 医学部 特別研究員
  • 2015/02 - 2018/03 Nagoya City University Graduate School of Pharmaceutical Sciences, Department of Biopharmaceutics
  • 2013/01 - 2015/01 National Institute of Environmental Health Sciences (NIEHS, NIH) Pharmacogenetics Visiting Fellow
Show all
Committee career (3):
  • 2024/08 - 現在 活性アミンに関するワークショップ 世話人
  • 2023/06 - 現在 THE JAPAN TRANSPORTER RESEARCH ASSOCIATION
  • 2021 - 現在 日本薬物動態学会 代議員
Awards (3):
  • 2018 - The Academy of Pharmaceutical Science and Technology, Japan (APSTJ) The APSTJ Global Education Seminar Presentation Award 2018
  • 2011 - American Society for Pharmacology and Experimental Therapeutics (ASPET, USA) James R. Gillette Drug Metabolism Best Paper of 2010
  • 2010 - 第5回トランスポーター研究会年会 優秀発表賞
Association Membership(s) (3):
THE ACADEMY OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY, JAPAN ,  THE JAPANESE SOCIETY FOR THE STUDY OF XENOBIOTICS ,  THE PHARMACEUTICAL SOCIETY OF JAPAN
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page